| produktnavn |
16,16-dimetylprostaglandin E2 |
| Synonymer |
16,16-dimetylprostaglandin E2; (5Z,11-alfa,13E,15R)-11,15-dihydroksy-16,16-dimetyl-9-oksoprosta-5,13-dien-1-syre; 16,16-dimetyl-pge2; 16,16-dimetyl-prostaglandin E2; 5-Heptensyre, 7-(2-(4,4-dimetyl-3-hydroksy-1-oktenyl)-3-hydroksy-5-oksocyklopentyl)-; 7-(2-(4,4-dimetyl-3-hydroksy-1-oktenyl)-3-hydroksy-5-oksocyklopentyl)-5-heptensyre; BRN 2896843; Prosta-5,13-dien-1-syre, 11,15-dihydroksy-16,16-dimetyl-9-okso-, (5Z,11-alfa,13E,15R)-; (5E,8beta,11beta,12xi,13E,15R)-11,15-dihydroksy-16,16-dimetyl-9-oksoprosta-5,13-dien-1-syre |
| Engelsk navn |
16,16-dimethylprostaglandin E2;16,16-Dimethylprostaglandin E2; (5Z,11-alpha,13E,15R)-11,15-Dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid; 16,16-Dimethyl-pge2; 16,16-Dimethyl-prostaglandin E2; 5-Heptenoic acid, 7-(2-(4,4-dimethyl-3-hydroxy-1-octenyl)-3-hydroxy-5-oxocyclopentyl)-; 7-(2-(4,4-Dimethyl-3-hydroxy-1-octenyl)-3-hydroxy-5-oxocyclopentyl)-5-heptenoic acid; BRN 2896843; Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11-alpha,13E,15R)-; (5E,8beta,11beta,12xi,13E,15R)-11,15-dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid |
| Molekylær Formel |
C22H36O5 |
| Molekylvekt |
380.5182 |
| InChI |
InChI=1/C22H36O5/c1-4-5-14-22(2,3)20(25)13-12-17-16(18(23)15-19(17)24)10-8-6-7-9-11-21(26)27/h6,8,12-13,16-17,19-20,24-25H,4-5,7,9-11,14-15H2,1-3H3,(H,26,27)/b8-6+,13-12+/t16-,17?,19-,20+/m0/s1 |
| CAS-nummer |
39746-25-3 |
| Molecular Structure |
|
| Tetthet |
1.119g/cm3 |
| Kokepunkt |
541.3°C at 760 mmHg |
| Brytningsindeks |
1.551 |
| Flammepunktet |
295.2°C |
| Damptrykk |
5.66E-14mmHg at 25°C |
| Hazard symboler |
|
| Risiko Koder |
|
| Sikkerhet Beskrivelse |
|
|
NO
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
PL
PT
RU
SA
TR
